What is the current price and volume for GV.PA stock pre-market?

GV.PA stock is trading at **€0.0018** pre-market with volume at **38,489,238** shares. The relative volume is about **2.71x** the average, indicating unusually high trading activity on Euronext.

How does Meyka AI rate GV.PA stock and why?

Meyka AI rates GV.PA with a score of **62.46 (Grade B)** and suggests HOLD. The grade factors in market and sector comparisons, financial growth, key metrics, forecasts and analyst sentiment.

What are the main financial risks for GV.PA stock?

Primary risks include negative EPS (**-0.11**), a weak current ratio (**0.91**), high debt-to-market-cap, and low market cap. These increase volatility and raise the chance of large moves on thin news.

What price target does Meyka AI forecast for GV.PA stock?

Meyka AI's forecast model projects **€0.005** for GV.PA. That implies roughly **177.78%** upside from **€0.0018**. Forecasts are model-based projections and not guarantees.

EU Stocks

€0.0018 pre-market GV.PA Genomic Vision Euronext Feb 13 2026: Liquidity focus

ByDanny Kontos February 13, 2026February 13, 2026

We see GV.PA stock trading at €0.0018 in the pre-market with heavy activity. Volume has surged to 38,489,238 shares, well above the 50-day average. This trading spike puts Genomic Vision (GV.PA) among the most active Euronext names this pre-market session. Traders are reacting to valuation gaps, thin market cap and the stock’s extreme volatility. We summarise why the move matters, the company metrics to watch, and what short-term traders should expect.